Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis
暂无分享,去创建一个
Lanjuan Li | Zeyu Sun | Zhongyang Xie | Huihui Zhu | Xiaoxi Ouyang | Zhengyi Jiang | Feiyang Ji | Menghao Zhou | Lingjian Zhang
[1] Zhikun Liu,et al. Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine , 2020, Cancer communications.
[2] Xiaolong Liu,et al. Proteomic analyses reveal divergent ubiquitylation patterns in hepatocellula carcinoma cell lines with different metastasis potential. , 2020, Journal of proteomics.
[3] C. Proud,et al. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3 , 2020, International journal of cancer.
[4] G. Duan,et al. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation , 2020, Molecular and Cellular Biology.
[5] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[6] C. Qin,et al. The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein , 2019, Cell Death & Differentiation.
[7] C. Sander,et al. LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer , 2019, Nature.
[8] R. Lothe,et al. Combination therapies with HSP90 inhibitors against colorectal cancer. , 2019, Biochimica et biophysica acta. Reviews on cancer.
[9] C. Proud,et al. Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress , 2019, The Journal of Biological Chemistry.
[10] Zhining Fan,et al. Upregulation of HRD1 promotes cell migration and invasion in colon cancer , 2018, Molecular and Cellular Biochemistry.
[11] Zhaojian Liu,et al. HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression. , 2018, Cellular signalling.
[12] Kenli Li,et al. iProX: an integrated proteome resource , 2018, Nucleic Acids Res..
[13] C. Proud,et al. Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer , 2017, Cancers.
[14] C. Croce,et al. MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma , 2017, Gastroenterology.
[15] A. Ciechanover,et al. The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy. , 2017, Trends in biochemical sciences.
[16] Yuki Hayashi,et al. Conserved cytoplasmic domains promote Hrd1 ubiquitin ligase complex formation for ER-associated degradation (ERAD) , 2017, Journal of Cell Science.
[17] G. Meng,et al. HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells , 2017, Nature Communications.
[18] F. He,et al. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network , 2017, Nature Communications.
[19] Yang Li,et al. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network , 2017, Nature Communications.
[20] Cheng Li,et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..
[21] D. Donoghue,et al. The importance of regulatory ubiquitination in cancer and metastasis , 2017, Cell cycle.
[22] Marco Y. Hein,et al. The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.
[23] S. Armstrong,et al. Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias. , 2015, Blood.
[24] Jin-hai Tang,et al. HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation , 2015, Oncotarget.
[25] C. Proud,et al. Regulated stability of eukaryotic elongation factor 2 kinase requires intrinsic but not ongoing activity. , 2015, The Biochemical journal.
[26] Jimin Zhu,et al. The role and therapeutic implications of RING‐finger E3 ubiquitin ligases in hepatocellular carcinoma , 2015, International journal of cancer.
[27] Michael N. Hall,et al. mTORC1 mediated translational elongation limits intestinal tumour initiation and growth , 2014, Nature.
[28] M. Gleave,et al. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer. , 2014, European urology.
[29] C. Proud,et al. Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles. , 2014, Advances in biological regulation.
[30] S. Carr,et al. Large-scale identification of ubiquitination sites by mass spectrometry , 2013, Nature Protocols.
[31] A. Kirschning,et al. Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy. , 2013, Natural product reports.
[32] A. Shaw,et al. Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer. , 2013, Cancer discovery.
[33] J. Hazle,et al. The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis , 2012, Cell.
[34] Jian-Bing Fan,et al. Gene-expression signature of vascular invasion in hepatocellular carcinoma. , 2011, Journal of hepatology.
[35] J. Llovet,et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. , 2009, Gastroenterology.
[36] P. Thuluvath. Vascular invasion is the most important predictor of survival in HCC, but how do we find it? , 2009, Journal of clinical gastroenterology.
[37] S. Yamasaki,et al. The Roles of Synoviolin in Crosstalk Between Endoplasmic Reticulum Stress-Induced Apoptosis and p53 Pathway , 2007, Cell cycle.
[38] Pier Paolo Pandolfi,et al. Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation , 2007, Nature Reviews Cancer.
[39] Daniela Hoeller,et al. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis , 2006, Nature Reviews Cancer.
[40] Yi Sun. E3 ubiquitin ligases as cancer targets and biomarkers. , 2006, Neoplasia.
[41] D. Reinberg,et al. Histone H2B Monoubiquitination Functions Cooperatively with FACT to Regulate Elongation by RNA Polymerase II , 2006, Cell.
[42] Sonia Arora,et al. Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase. , 2005, Cancer research.
[43] R. Zeng,et al. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97‐H and MHCC97‐L, with different metastasis potentials , 2004, Proteomics.
[44] M. Chung,et al. Proteome database of hepatocellular carcinoma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[45] W. Hait,et al. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin. , 2001, Cancer research.
[46] A. Weissman. Ubiquitin and proteasomes: Themes and variations on ubiquitylation , 2001, Nature Reviews Molecular Cell Biology.
[47] A. Hershko. Ubiquitin-mediated protein degradation. , 1988, The Journal of biological chemistry.
[48] A. Hershko,et al. Ubiquitin-activating enzyme. Mechanism and role in protein-ubiquitin conjugation. , 1982, The Journal of biological chemistry.
[49] A Ciechanover,et al. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[50] A. Burroughs,et al. A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability , 2012, Annals of Surgical Oncology.
[51] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[52] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.